Department of Surgery, University of Cambridge, Cambridge, United Kingdom.
Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Transplantation. 2020 May;104(5):1019-1025. doi: 10.1097/TP.0000000000002907.
The benefits of cold pulsatile machine perfusion (MP) for the storage and transportation of kidneys donated after circulatory death are disputed. We conducted a UK-based multicenter, randomized controlled trial to compare outcomes of kidneys stored with MP versus static cold storage (CS).
Fifty-one pairs of kidneys donated after circulatory death were randomly allocated to receive static CS or cold pulsatile MP. The primary endpoint, delayed graft function, was analyzed by "intention-to-treat" evaluation.
There was no difference in the incidence of delayed graft function between CS and MP (32/51 (62.8%) and 30/51 (58.8%) P = 0.69, respectively), although the trial stopped early due to difficulty with recruitment. There was no difference in the incidence of acute rejection, or in graft or patient survival between the CS and MP groups. Median estimated glomerular filtration rate at 3 months following transplantation was significantly lower in the CS group compared with MP (CS 34 mL/min IQR 26-44 vs MP 45 mL/min IQR 36-60, P = 0.006), although there was no significant difference in estimated glomerular filtration rate between CS and MP at 12 months posttransplant.
This study is underpowered, which limits definitive conclusions about the use of MP, as an alternative to static CS. It did not demonstrate that the use of MP reduces the incidence of delayed graft function in donation after circulatory death kidney transplantation.
冷脉冲机器灌注(MP)在保存和运输心跳停止后捐献的肾脏方面的益处存在争议。我们进行了一项英国多中心、随机对照试验,比较了使用 MP 保存与静态低温保存(CS)的肾脏结局。
51 对心跳停止后捐献的肾脏随机分配接受静态 CS 或冷脉冲 MP。主要终点,即延迟移植物功能,通过“意向治疗”评估进行分析。
CS 和 MP 组的延迟移植物功能发生率没有差异(CS 为 32/51(62.8%)和 MP 为 30/51(58.8%),P=0.69),尽管由于招募困难,试验提前停止。CS 和 MP 组之间的急性排斥反应发生率、移植物或患者存活率没有差异。移植后 3 个月时,CS 组的估计肾小球滤过率中位数明显低于 MP 组(CS 为 34ml/min IQR 26-44,MP 为 45ml/min IQR 36-60,P=0.006),但移植后 12 个月时 CS 和 MP 组的估计肾小球滤过率没有差异。
本研究的样本量不足,限制了对 MP 作为 CS 的替代物的使用是否能降低心跳停止后捐献肾脏移植中延迟移植物功能发生率的明确结论。它没有证明 MP 的使用可以降低心跳停止后捐献肾脏移植中延迟移植物功能的发生率。